Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The research protocol received ethical clearance from the Institutional Review Board of the First Affiliated Hospital of Nanjing Medical University
Our current results demonstrated that CCL11 exerted chemotaxis of HUVECs in a dose-dependent manner and the angiogenic capacity proved by recombinant human CCL11 and CCL11 antibody
Yes, the weekly dose can be divided across three injections on Monday, Wednesday, and Friday
US penetration today is around 12% of adults and changes in regulation, increased availability, lower cost from generics and new modalities (such as the pill) are driving future adoption
US$ 29.76
US$ 21.27
US$ 23.99
